We present evidence that poliovirus can be encapsulated in synthetic large phospholipid vesicles. The virus associated with the vesicles is found to be (i) resistant to antiserum against poliovirus and (ii) infectious for cells that are normally resistant to virus infection because of a membrane restriction. Our interpretation of these results is that the virus is entrapped in the interior aqueous space of the vesicles and that this vesicle-associated virus is introduced directly into the cytoplasm of the cells via fusion of the vesicles with the cellular plasma membrane, bypassing the surface receptor-mediated restriction.
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Synthetic lipid vesicles [often referred to as liposomes (1, 2) ] have been widely discussed as vehicles for the introduction of foreign materials into eukaryotic cells (3) (4) (5) . Several groups have successfully introduced a variety of biologically active molecules into cells by this method (6) (7) (8) (9) (10) . All of the experiments reported so far, however, have used either small unilamellar or multilamellar vesicles that restrict the size and stability characteristics of the molecules to be encapsulated. Many interesting experiments require an encapsulation process that produces vesicles with a large interior aqueous space that can accommodate large macromolecules or molecular aggregates efficiently, but avoids extremes of pH, temperature, detergents, solvents, or sonication. Furthermore, the vesicles must be capable of introducing their contents into the cytoplasm of a cell under physiological conditions. We have previously described a technique for making large unilamellar vesicles (LUV) which involves the fusion of small phosphatidylserine (PtdSer) vesicles by Ca2+, and subsequent removal of Ca2+ by EDTA (11) .
Vesicles prepared from bovine PtdSer, a negatively charged lipid which is fluid at physiological temperatures, are taken up by cells primarily by fusion with the plasma membrane rather than by endocytosis (12) . In this paper we present evidence that a large (8 X 106 dalton) molecular aggregate, a picornavirus, can be efficiently encapsulated in LUVs and that this vesicleassociated virus is biologically active when exposed to cells.
Poliovirus, a small nonenveloped plus-strand RNA virus, is easily grown and purified, and simple virus plaque assays provide an unambiguous, sensitive assay system. The virion contains no lipid; thus infection of cells does not initially involve membrane-membrane interactions. Poliovirus requires a primate-specific membrane receptor for normal infection, and the absence of this receptor on the surface of non-primate cells makes them virus-resistant (13, 14) . This system has allowed us to test not only whether the encapsulated virus is biologically active but also whether the membrane-mediated restriction of resistant cells can be bypassed by introducing the virion into the cell via a vesicle. Vesicle Preparation. The techniques for making large unilamellar vesicles via Ca2+-induced phase changes in the lipid were described by Papahadjopoulos et al. (11) ; the techniques for encapsulation are described in the Results. A brief summary follows. Chromatographically pure PtdSer from bovine brain (15) plus a trace amount of 3H-labeled dipalmitoylphosphatidylcholine (9) is suspended by vortex mixing for 10 min in NaCl/His/Tes buffer at 10,mol/ml followed by sonication for 1 hr at 250 in a closed tube placed in a bath-type ultrasonic cleaner (model T-80-80-lRS, Laboratory Supplies, Hicksville, NY). The solution is kept under nitrogen throughout this procedure to minimize oxidation of the lipid. Ca2+ is introduced either by direct addition of 100 mM CaC12 to the sonicated solution (final concentration 10 mM) and incubation at 370 for 1 hr, or by dialysis of the solution against buffer containing 100
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§1734 solely to indicate this fact. tamination by cell membrane components. Clarified supernatants from infected cells are subjected to high-speed centrifugation and the resulting pellets are resuspended and layered onto sucrose gradients containing sodium dodecyl sulfate as described in the legend of Fig. 1 . The peak fractions from such a gradient are pooled, pelleted, washed twice to remove any residual detergent, and resuspended in a small volume of buffer solution containing 100 mM NaCl, 2 mM histidine, 2 mM Tes, and 0.1 mM EDTA, at pH 7.4. The technique for preparing large unilamellar vesicles of PtdSer encompassing foreign material are essentially those previously described (11) . Minor modifications were outlined in Materials and Methods. Purified PtdSer plus a trace amount of 3H-labeled dipalmitoylphosphatidylcholine (DPPC) is suspended in buffer by sonication, resulting in dispersion of the lipid into small unilamellar vesicles 200-00 A in diameter (11) . Addition of CaCl2 produces a white flocculent precipitate which, when examined by freeze-fracture electron microscopy, appears to be rolls of large lipid lamellae that we have termed cochleate cylinders (11 Fractions from virus-containing Ficoll step gradients are titered on sensitive (HeLa) cells before and after exposure to poliovirusneutralizing antiserum (Ab); fractions from a preparation of vesicles alone are tested for overt cytotoxic effects. Virus in 10-fold dilutions is adsorbed to HeLa cells for 3 hr at 370, the inoculum is washed away, and fresh medium is added to the monolayers. After a 2-day incubation, the plates are stained and plaques are counted. Titers are expressed in plaque-forming units/ml (PFU/ml), rounded off to the nearest factor of 5. Recovery of onput infectivity was 95-100%. *Control: virus alone (30% Ficoll fraction) mixed with vesicles alone (2% Ficoll fraction).
higher titer than a parallel fraction (2% Ficoll) from a gradient containing virus alone, suggesting that the lipid-virus complex is infectious. Antiserum treatment of fractions containing virus but no lipid results in a 104-fold reduction of infectivity. Similar treatment of an encapsulated virus fraction reduces the titer by only 10-fold, indicating that a substantial fraction of this virus is not subject to the neutralizing action of the antiserum. Control experiments indicate that preformed vesicles do not inhibit antibody-mediated neutralization of the virus. Our interpretation of the antiserum resistance is that the virus is inside the vesicles, the lipid bilayer forming a barrier between encapsulated virions and external antibody molecules. A possible explanation for the disparity in the titer of the encapsulated virus fraction before and after antiserum treatment lies in the expected efficiency of infection with free versus encapsulated virus. In the absence of antibody unencapsulated virus can initiate an infection by the normal route, whereas encapsulated virus requires both interaction between the lipid vesicle and the cell and subsequent initiation of infection by the virus. Preliminary data indicate that only about 1% of the vesicle population becomes cell associated. This indicates that the infectious process with encapsulated virus may be considerably less efficient than normal infection, giving a titer biased in favor of the free virus present as a contaminant or virus released by lysis or breakage of the vesicles.
We have used Chinese hamster ovary (CHO) cells to test the ability of vesicle-associated poliovirus to bypass the receptormediated restriction of non-primate cells. Cells are exposed to encapsulated or naked virus fractions, washed with antibody after 3 hr, and tested for their ability to form infectious centers when overlayed on permissive cell monolayers. The data presented in Table 3 demonstrate that only encapsulated poliovirus is capable of infecting CHO cells. When a parallel sample of encapsulated poliovirus is subjected to the same treatment in the absence of CHO cells, no infectious centers are formed, indicating that virus-containing vesicles alone are not responsible for the infections. When virus and preformed vesicles are mixed with cells under the same conditions, infectious centers are produced at a very low level of efficiency. Several mechanisms could be responsible for these latter infections: virus could be trapped during a fusion event between a vesicle and a cell, entering the cytoplasm during the rearrangement of the membrane; virus could be similarly trapped during a vesicle- Table 2. induced fusion between two cells (16); or virus could be "encapsulated" when two vesicles fuse with each other. The fact that infectious cpnters are formed at a significantly higher efficiency by encapsulated virus than by virus mixed with preformed vesicles indicates that these mechanisms are not responsible for the ability of the vesicle encapsulated virus to overcome the receptor restriction. The most likely mechanism for the infectious properties of this virus is fusion of the lipid vesicle with the cell and release of the encapsulated virus into the cytoplasm.
Additional data demonstrating the infection of CHO cells with encapsulated virus is provided by experiments measuring the ability of the encapsulated virus to replicate in resistant cells. CHO cells are exposed to gradient fractions containing encapsulated virus, virus alone, or virus plus preformed vesicles. After the inoculum is washed away, the cell supernatants are titered on permissive cells at 0 and 16 hr. The data in Table 4 indicate that CHO (1, 2) . (ii) Other macromolecules such as synthetic polynucleotides (17) and ferritin show similar efficiencies of entrapment. Freeze-fracture electron microscopy of LUV reveals spherical structures containing visible ferritin molecules within the interior aqueous Several facets of this system are now available for study. The relative efficiencies of infection of encapsulated virii$verusus virus alone in susceptible cells can be determined. It might also be possible to-use this vesicle system to infect virus-resistant cells with purified poliovirus RNA. We feel this latter system could be very useful if we could improve upon previously reported efficiencies of RNA infection of cells (18) . We have shown that synthetic double-stranded RNA molecules apparently can be introduced into cells via vesicles, but these structures represent unusually stable molecules without size or information constraints (19) . The potential for extending the poliovirus and poliovirus RNA model systems to include insertion of mRNAs and other genetically active material is apparent and we hope to proceed in this direction.
The results reported here also suggest a useful model system for studying the interaction of picornaviruses with cells. It is clear that we have subverted the membrane restriction on poliovirus-hamster cell interaction, but the details of this infectious process are not understood. As discussed above, it is possible that the vesicles fuse with the cell membranes, emptying their contents into the cytoplasm. If this is the introductory mechanism, one wonders where the alterations in picornavirus structure that are part of normal infection occur. LonborgHolm has demonstrated (17) that upon association with cellular membranes, poliovirus assumes at least one identifiable intermediate form, designated the "A particle". It could now be possible to determine whether this intermediate can be detected upon association of virus with the lipid bilayer or whether it appears upon addition of the virus-vesicle complex to cells. The results of Lonborg-Holm using neutral lipid vesicles suggest that the structural alteration increases the lipophilic properties of the virus because only "A particles" associate with such vesicles (20) .
In conclusion, phospholipid vesicles are a simple and efficient system for the introduction of biologically active macromolecules into cells; they may also represent a useful model system for the study of interactions of nonenveloped viruses with cell membranes.
